3
项与 HUC-MSC-sEV-001 Nasal Drops(Xuanwu Hospital ) 相关的临床试验 / Not yet recruiting临床1/2期IIT Human Umbilical Cord Mesenchymal Stem Cell-derived ExoSomes for Autoimmune Encephalitis: a Phase I/IIa Clinical Trial (MESAE)
This is a phase I/IIa study to investigate the safety and preliminary efficacy of intranasal admnistration of human umbilical mesenchymal stem cell-derived exosome (hUC-MSC-Exo) for patients with autoimmune encephalitis.
/ Not yet recruiting临床1期IIT A Multi-center, Open, Single-arm, Basket-design Clinical Trial to Evaluate the Safety and Efficacy of Human Umbilical Cord Mesenchymal Stem Cell-derived Small Extracellular Vesicles hUC-MSC-sEV-001 Nasal Drops for the Treatment of Multiple Neurodegenerative Diseases
To evaluate the safety and preliminary efficacy of human umbilical cord mesenchymal stem cell-derived small extracellular vesicles hUC-MSC-sEV-001 nasal drops in multiple neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, multiple system atrophy, Lewy body dementia, frontotemporal dementia, and amyotrophic lateral sclerosis.
An Exploratory Study on the Use of Intranasal Administration of Small Extracellular Vesicles for the Treatment of Amyotrophic Lateral Sclerosis
This is a multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial. The goal of this clinical trial is to evaluate the safety and preliminary efficacy of nasal drop exosomes derived from human umbilical cord blood mesenchymal stem cells (hUC-MSC-sEV-001) in amyotrophic lateral sclerosis.
100 项与 HUC-MSC-sEV-001 Nasal Drops(Xuanwu Hospital ) 相关的临床结果
100 项与 HUC-MSC-sEV-001 Nasal Drops(Xuanwu Hospital ) 相关的转化医学
100 项与 HUC-MSC-sEV-001 Nasal Drops(Xuanwu Hospital ) 相关的专利（医药）
100 项与 HUC-MSC-sEV-001 Nasal Drops(Xuanwu Hospital ) 相关的药物交易
